US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist

173.040
-0.880-0.51%

Close Nov 8 16:00 ET

173.040
0.0000.00%

Post 20:01 ET

25.22BMarket Cap15.65P/E (TTM)

Biogen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-25.73%1.7B

-68.59%1.91B

-78.69%1.07B

-78.54%1.05B

-53.41%2.29B

26.69%6.08B

34.37%5.04B

28.67%4.89B

-Cash and cash equivalents

-25.73%1.7B

-27.08%1.91B

-62.93%1.07B

-69.29%1.05B

-37.75%2.29B

-1.09%2.62B

65.68%2.9B

51.20%3.42B

-Short-term investments

----

--0

60.86%3.46B

7.03%2.14B

-4.39%1.47B

Receivables

-10.03%1.99B

-2.16%2.08B

-1.41%2B

-1.70%2.1B

11.36%2.21B

6.01%2.12B

0.34%2.03B

8.91%2.14B

-Accounts receivable

-10.03%1.99B

-2.16%2.08B

-1.41%2B

-1.70%2.1B

11.36%2.21B

6.01%2.12B

0.34%2.03B

8.91%2.14B

Inventory

-17.21%2.47B

87.93%2.51B

96.47%2.52B

87.99%2.53B

116.90%2.98B

3.04%1.33B

5.40%1.28B

-0.53%1.34B

Other current assets

-30.81%674M

-31.32%615.3M

-17.47%1.17B

-16.62%1.18B

-34.86%974.1M

-45.55%895.9M

52.25%1.41B

91.36%1.42B

Total current assets

-19.20%6.83B

-31.86%7.11B

-30.79%6.76B

-29.94%6.86B

-13.43%8.45B

7.09%10.43B

23.33%9.76B

24.63%9.79B

Non current assets

Net PPE

-4.55%3.59B

-0.95%3.64B

0.09%3.7B

0.73%3.73B

1.94%3.76B

-0.07%3.67B

-0.85%3.7B

-2.36%3.7B

-Gross PPE

1.48%6.2B

3.70%6.18B

4.28%6.17B

4.50%6.13B

5.46%6.11B

2.56%5.96B

1.80%5.92B

1.20%5.87B

-Accumulated depreciation

-11.17%-2.6B

-11.19%-2.54B

-11.27%-2.47B

-10.93%-2.4B

-11.66%-2.34B

-7.09%-2.28B

-6.54%-2.22B

-7.93%-2.17B

Goodwill and other intangible assets

15.12%16.29B

92.03%14.46B

91.83%14.51B

91.89%14.58B

82.61%14.15B

-3.77%7.53B

-4.35%7.57B

-4.80%7.6B

-Goodwill

-4.73%6.49B

8.23%6.23B

8.27%6.23B

8.18%6.22B

18.57%6.81B

0.07%5.75B

-0.11%5.75B

-0.21%5.75B

-Other intangible assets

33.51%9.81B

363.46%8.23B

356.89%8.28B

352.03%8.36B

265.60%7.34B

-14.40%1.78B

-15.69%1.81B

-16.71%1.85B

Investments and advances

----

--0

-99.99%100K

9.53%1.21B

-2.34%978.2M

-20.89%705.7M

Non current deferred assets

-9.45%968.7M

-24.27%915.1M

-25.87%898.3M

-24.28%928.6M

-8.91%1.07B

-2.21%1.21B

-5.97%1.21B

-13.33%1.23B

Other non current assets

-16.33%631.4M

-38.32%681.5M

-49.48%697.6M

-51.28%745M

-53.21%754.6M

-26.38%1.1B

-21.88%1.38B

-21.15%1.53B

Total non current assets

8.83%21.48B

33.76%19.7B

33.54%19.81B

35.38%19.99B

30.82%19.74B

-4.01%14.73B

-5.49%14.84B

-7.85%14.76B

Total assets

0.43%28.31B

6.55%26.8B

8.01%26.57B

9.33%26.84B

13.43%28.19B

0.30%25.16B

4.17%24.6B

2.83%24.55B

Liabilities

Current liabilities

Payables

34.79%921.8M

-9.82%636.1M

-14.93%618.2M

-12.07%660.7M

10.22%683.9M

-1.99%705.4M

1.49%726.7M

-1.64%751.4M

-accounts payable

-3.95%422.7M

-20.41%354.5M

-21.21%387M

-17.95%403.3M

14.85%440.1M

2.44%445.4M

23.20%491.2M

-16.58%491.5M

-Total tax payable

104.72%499.1M

8.31%281.6M

-1.83%231.2M

-0.96%257.4M

2.74%243.8M

-8.74%260M

-25.78%235.5M

48.77%259.9M

Current accrued expenses

-48.65%1.83B

-30.23%1.55B

-29.76%1.48B

5.16%1.45B

19.02%3.56B

-26.16%2.23B

3.78%2.1B

-37.04%1.38B

Current debt and capital lease obligation

249.62%1.75B

----

--250M

--150M

--500M

----

-Current debt

249.62%1.75B

----

--250M

--150M

--500M

----

Other current liabilities

--637.4M

--689.5M

--714.8M

12.25%838.4M

----

--746.9M

Current liabilities

8.02%5.43B

-2.46%3.11B

6.90%3.22B

4.93%3.43B

27.91%5.02B

-36.50%3.19B

-23.61%3.01B

-23.86%3.27B

Non current liabilities

Long term debt and capital lease obligation

-32.05%4.9B

1.07%6.66B

1.31%6.7B

8.68%7.19B

8.76%7.22B

0.57%6.59B

0.33%6.61B

0.15%6.61B

-Long term debt

-33.02%4.55B

0.12%6.29B

8.08%6.79B

0.11%6.28B

-Long term capital lease obligation

-16.74%357M

20.73%367.5M

24.31%406.5M

20.12%400M

20.86%428.8M

11.01%304.4M

4.71%327M

0.79%333M

Non current deferred liabilities

21.19%882.4M

310.42%590.6M

161.88%658.1M

91.75%641.8M

121.37%728.1M

-70.06%143.9M

-56.00%251.3M

-51.81%334.7M

Other non current liabilities

-22.17%582.1M

-53.02%365M

-60.87%366.1M

-17.27%781.1M

-37.58%747.9M

-33.47%776.9M

-27.36%935.5M

-28.50%944.2M

Total non current liabilities

-24.87%6.53B

3.95%7.81B

4.30%8.13B

9.10%8.61B

6.50%8.69B

-8.42%7.51B

-7.70%7.8B

-8.43%7.89B

Total liabilities

-12.83%11.95B

2.04%10.92B

5.02%11.35B

7.88%12.05B

13.45%13.71B

-19.08%10.7B

-12.77%10.81B

-13.56%11.17B

Shareholders'equity

Share capital

0.00%100K

-common stock

0.00%100K

-Preferred stock

--0

Retained earnings

9.29%18.99B

6.64%18.6B

6.92%18.02B

7.05%17.63B

9.18%17.38B

16.62%17.45B

18.56%16.85B

18.36%16.47B

Paid-in capital

101.69%488.5M

138.72%407.5M

261.29%329.5M

312.69%302.5M

--242.2M

--170.7M

-23.36%91.2M

7.48%73.3M

Less: Treasury stock

0.00%2.98B

Gains losses not affecting retained earnings

8.54%-145.7M

15.51%-146M

6.69%-160.5M

6.79%-153.7M

2.63%-159.3M

-56.52%-172.8M

-49.31%-172M

-54.55%-164.9M

Total stockholders'equity

12.95%16.36B

9.83%15.89B

10.27%15.21B

10.46%14.8B

13.37%14.48B

21.85%14.47B

22.72%13.8B

22.96%13.4B

Noncontrolling interests

----

--0

52.87%-4.1M

29.67%-6.4M

55.56%-9.6M

-114.96%-9.5M

Total equity

12.98%16.36B

9.88%15.89B

10.34%15.21B

10.54%14.8B

13.42%14.48B

21.89%14.46B

22.87%13.79B

22.16%13.39B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-25.73%1.7B	-68.59%1.91B	-78.69%1.07B	-78.54%1.05B	-78.54%1.05B	-53.41%2.29B	26.69%6.08B	34.37%5.04B	28.67%4.89B	28.67%4.89B
-Cash and cash equivalents	-25.73%1.7B	-27.08%1.91B	-62.93%1.07B	-69.29%1.05B	-69.29%1.05B	-37.75%2.29B	-1.09%2.62B	65.68%2.9B	51.20%3.42B	51.20%3.42B
-Short-term investments	----	----	----	--0	--0	--0	60.86%3.46B	7.03%2.14B	-4.39%1.47B	-4.39%1.47B
Receivables	-10.03%1.99B	-2.16%2.08B	-1.41%2B	-1.70%2.1B	-1.70%2.1B	11.36%2.21B	6.01%2.12B	0.34%2.03B	8.91%2.14B	8.91%2.14B
-Accounts receivable	-10.03%1.99B	-2.16%2.08B	-1.41%2B	-1.70%2.1B	-1.70%2.1B	11.36%2.21B	6.01%2.12B	0.34%2.03B	8.91%2.14B	8.91%2.14B
Inventory	-17.21%2.47B	87.93%2.51B	96.47%2.52B	87.99%2.53B	87.99%2.53B	116.90%2.98B	3.04%1.33B	5.40%1.28B	-0.53%1.34B	-0.53%1.34B
Other current assets	-30.81%674M	-31.32%615.3M	-17.47%1.17B	-16.62%1.18B	-16.62%1.18B	-34.86%974.1M	-45.55%895.9M	52.25%1.41B	91.36%1.42B	91.36%1.42B
Total current assets	-19.20%6.83B	-31.86%7.11B	-30.79%6.76B	-29.94%6.86B	-29.94%6.86B	-13.43%8.45B	7.09%10.43B	23.33%9.76B	24.63%9.79B	24.63%9.79B
Non current assets
Net PPE	-4.55%3.59B	-0.95%3.64B	0.09%3.7B	0.73%3.73B	0.73%3.73B	1.94%3.76B	-0.07%3.67B	-0.85%3.7B	-2.36%3.7B	-2.36%3.7B
-Gross PPE	1.48%6.2B	3.70%6.18B	4.28%6.17B	4.50%6.13B	4.50%6.13B	5.46%6.11B	2.56%5.96B	1.80%5.92B	1.20%5.87B	1.20%5.87B
-Accumulated depreciation	-11.17%-2.6B	-11.19%-2.54B	-11.27%-2.47B	-10.93%-2.4B	-10.93%-2.4B	-11.66%-2.34B	-7.09%-2.28B	-6.54%-2.22B	-7.93%-2.17B	-7.93%-2.17B
Goodwill and other intangible assets	15.12%16.29B	92.03%14.46B	91.83%14.51B	91.89%14.58B	91.89%14.58B	82.61%14.15B	-3.77%7.53B	-4.35%7.57B	-4.80%7.6B	-4.80%7.6B
-Goodwill	-4.73%6.49B	8.23%6.23B	8.27%6.23B	8.18%6.22B	8.18%6.22B	18.57%6.81B	0.07%5.75B	-0.11%5.75B	-0.21%5.75B	-0.21%5.75B
-Other intangible assets	33.51%9.81B	363.46%8.23B	356.89%8.28B	352.03%8.36B	352.03%8.36B	265.60%7.34B	-14.40%1.78B	-15.69%1.81B	-16.71%1.85B	-16.71%1.85B
Investments and advances	----	----	----	--0	--0	-99.99%100K	9.53%1.21B	-2.34%978.2M	-20.89%705.7M	-20.89%705.7M
Non current deferred assets	-9.45%968.7M	-24.27%915.1M	-25.87%898.3M	-24.28%928.6M	-24.28%928.6M	-8.91%1.07B	-2.21%1.21B	-5.97%1.21B	-13.33%1.23B	-13.33%1.23B
Other non current assets	-16.33%631.4M	-38.32%681.5M	-49.48%697.6M	-51.28%745M	-51.28%745M	-53.21%754.6M	-26.38%1.1B	-21.88%1.38B	-21.15%1.53B	-21.15%1.53B
Total non current assets	8.83%21.48B	33.76%19.7B	33.54%19.81B	35.38%19.99B	35.38%19.99B	30.82%19.74B	-4.01%14.73B	-5.49%14.84B	-7.85%14.76B	-7.85%14.76B
Total assets	0.43%28.31B	6.55%26.8B	8.01%26.57B	9.33%26.84B	9.33%26.84B	13.43%28.19B	0.30%25.16B	4.17%24.6B	2.83%24.55B	2.83%24.55B
Liabilities
Current liabilities
Payables	34.79%921.8M	-9.82%636.1M	-14.93%618.2M	-12.07%660.7M	-12.07%660.7M	10.22%683.9M	-1.99%705.4M	1.49%726.7M	-1.64%751.4M	-1.64%751.4M
-accounts payable	-3.95%422.7M	-20.41%354.5M	-21.21%387M	-17.95%403.3M	-17.95%403.3M	14.85%440.1M	2.44%445.4M	23.20%491.2M	-16.58%491.5M	-16.58%491.5M
-Total tax payable	104.72%499.1M	8.31%281.6M	-1.83%231.2M	-0.96%257.4M	-0.96%257.4M	2.74%243.8M	-8.74%260M	-25.78%235.5M	48.77%259.9M	48.77%259.9M
Current accrued expenses	-48.65%1.83B	-30.23%1.55B	-29.76%1.48B	5.16%1.45B	5.16%1.45B	19.02%3.56B	-26.16%2.23B	3.78%2.1B	-37.04%1.38B	-37.04%1.38B
Current debt and capital lease obligation	249.62%1.75B	----	--250M	--150M	--150M	--500M	----	----	----	----
-Current debt	249.62%1.75B	----	--250M	--150M	--150M	--500M	----	----	----	----
Other current liabilities	--637.4M	--689.5M	--714.8M	12.25%838.4M	12.25%838.4M	----	----	----	--746.9M	--746.9M
Current liabilities	8.02%5.43B	-2.46%3.11B	6.90%3.22B	4.93%3.43B	4.93%3.43B	27.91%5.02B	-36.50%3.19B	-23.61%3.01B	-23.86%3.27B	-23.86%3.27B
Non current liabilities
Long term debt and capital lease obligation	-32.05%4.9B	1.07%6.66B	1.31%6.7B	8.68%7.19B	8.68%7.19B	8.76%7.22B	0.57%6.59B	0.33%6.61B	0.15%6.61B	0.15%6.61B
-Long term debt	-33.02%4.55B	0.12%6.29B	0.12%6.29B	8.08%6.79B	8.08%6.79B	8.08%6.79B	0.11%6.28B	0.11%6.28B	0.11%6.28B	0.11%6.28B
-Long term capital lease obligation	-16.74%357M	20.73%367.5M	24.31%406.5M	20.12%400M	20.12%400M	20.86%428.8M	11.01%304.4M	4.71%327M	0.79%333M	0.79%333M
Non current deferred liabilities	21.19%882.4M	310.42%590.6M	161.88%658.1M	91.75%641.8M	91.75%641.8M	121.37%728.1M	-70.06%143.9M	-56.00%251.3M	-51.81%334.7M	-51.81%334.7M
Other non current liabilities	-22.17%582.1M	-53.02%365M	-60.87%366.1M	-17.27%781.1M	-17.27%781.1M	-37.58%747.9M	-33.47%776.9M	-27.36%935.5M	-28.50%944.2M	-28.50%944.2M
Total non current liabilities	-24.87%6.53B	3.95%7.81B	4.30%8.13B	9.10%8.61B	9.10%8.61B	6.50%8.69B	-8.42%7.51B	-7.70%7.8B	-8.43%7.89B	-8.43%7.89B
Total liabilities	-12.83%11.95B	2.04%10.92B	5.02%11.35B	7.88%12.05B	7.88%12.05B	13.45%13.71B	-19.08%10.7B	-12.77%10.81B	-13.56%11.17B	-13.56%11.17B
Shareholders'equity
Share capital	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K
-common stock	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K	0.00%100K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	9.29%18.99B	6.64%18.6B	6.92%18.02B	7.05%17.63B	7.05%17.63B	9.18%17.38B	16.62%17.45B	18.56%16.85B	18.36%16.47B	18.36%16.47B
Paid-in capital	101.69%488.5M	138.72%407.5M	261.29%329.5M	312.69%302.5M	312.69%302.5M	--242.2M	--170.7M	-23.36%91.2M	7.48%73.3M	7.48%73.3M
Less: Treasury stock	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B	0.00%2.98B
Gains losses not affecting retained earnings	8.54%-145.7M	15.51%-146M	6.69%-160.5M	6.79%-153.7M	6.79%-153.7M	2.63%-159.3M	-56.52%-172.8M	-49.31%-172M	-54.55%-164.9M	-54.55%-164.9M
Total stockholders'equity	12.95%16.36B	9.83%15.89B	10.27%15.21B	10.46%14.8B	10.46%14.8B	13.37%14.48B	21.85%14.47B	22.72%13.8B	22.96%13.4B	22.96%13.4B
Noncontrolling interests	----	----	----	--0	--0	52.87%-4.1M	29.67%-6.4M	55.56%-9.6M	-114.96%-9.5M	-114.96%-9.5M
Total equity	12.98%16.36B	9.88%15.89B	10.34%15.21B	10.54%14.8B	10.54%14.8B	13.42%14.48B	21.89%14.46B	22.87%13.79B	22.16%13.39B	22.16%13.39B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Cancer Research

Intraday-0.22%